General Technology Venture Capital

Eplus3D is a manufacturer and developer focused on industrial-grade 3D printing systems and application technologies, emphasizing research and development in additive manufacturing. The company utilizes advanced technologies such as MPBF™ (Metal Powder Bed Fusion), PPBF™ (Polymer Powder Bed Fusion), and stereolithography to create professional application solutions. Eplus3D serves various sectors, including aerospace, automotive, tooling, healthcare, dental, consumer goods, and precision manufacturing. By promoting its innovative 3D printing technologies, Eplus3D aims to enhance industrial capabilities and provide tailored solutions for high-performance manufacturing needs.

Suzhou Kerun New Materials is an enterprise focusing on the R&D and production of perfluorinated ion membranes for fuel cell proton exchange membranes, vanadium batteries, and hydrogen production by electrolysis in the field of clean energy. The company was founded by Mr. Yang Dawei.

Deep Vision is a supplier of high-precision intelligent visual inspection solutions in the industrial field. Deep Vision has independent research and development capabilities of intelligent AI cameras & 3D cameras, optical design capabilities, research and development capabilities of multiple algorithm libraries, research and development capabilities of FPGA platform image acquisition and processing systems, and design and manufacturing capabilities of automation equipment.

MeetFuture China is a technology-driven company specializing in automated transmission systems for the pan-semiconductor industry. Established in 2016, it offers innovative automation solutions aimed at enhancing industrial upgrading and development. The company leverages control theory, computer technology, and information systems to deliver effective industrial detection, control, optimization, dispatch, and management solutions. By implementing these advanced technologies, MeetFuture enables its clients to reduce operational costs and optimize production parameters, thereby improving overall efficiency and productivity in the semiconductor sector.

Yikon Genomics Co., Ltd. is a Beijing-based company specializing in the development and supply of genetic analytical products and services focused on single-cell sequencing. Established in 2012, Yikon utilizes patented MALBAC technology to offer a range of solutions aimed at improving reproductive health and cancer diagnostics, including liquid tumor biopsy. Its product line features the MALBAC single cell whole genome amplification kit, along with companion kits designed for various applications such as copy number variation and single nucleotide variant analysis. The company also provides services such as single-cell DNA genome sequencing and whole human genome re-sequencing. Yikon's innovation has been significant in the fields of prenatal and postnatal care as well as early tumor detection, empowering healthcare professionals with accurate and efficient diagnostic tools.

Percutek Therapeutics is a manufacturer focused on the research, development, and production of minimally invasive interventional medical devices for cardiovascular applications. The company specializes in devices that facilitate non-invasive diagnosis and treatment of cardiovascular conditions, targeting areas such as the aorta, peripheral and coronary vasculature, as well as nerve intervention. Percutek Therapeutics is committed to delivering safe and effective solutions that enhance the treatment of vascular diseases, thereby improving patient outcomes in cardiovascular care.

Founded in 2011, 7LeKang operates nine offline stores and an online pharmacy platform

Cygnus Biosciences (Beijing) Co., Ltd. is a biotechnology firm focused on the research and development of gene sequencing platforms. The company is dedicated to the industrialization of these technologies for clinical medicine screening and diagnosis. By leveraging advanced gene sequencing technology, Cygnus provides accurate and efficient biotech solutions, enabling genetic engineers and gene therapy specialists to obtain reliable data inputs and readings. This capability supports researchers in conducting experiments and deriving conclusions with enhanced effectiveness and minimal error. Through its innovative approach, Cygnus Biosciences aims to advance the field of genetics and improve clinical outcomes.

MemBlaze is a Beijing-based company specializing in the production of memory cards and solid-state drives (SSDs) designed for enterprise applications. The firm focuses on developing enterprise-class NVMe (Non-Volatile Memory Express) SSDs, which are utilized across various sectors including databases, virtualization, cloud computing, big data, and artificial intelligence. MemBlaze's products cater to the needs of businesses in internet services, cloud computing, finance, and telecommunications, offering stable and reliable high-speed storage solutions that enhance operational efficiency.

QuantiHealth is a biotechnology company specializing in microbial testing solutions. It offers standardized sampling kits designed to prevent contamination and degradation of biological samples throughout the sampling, transportation, and storage processes. QuantiHealth collaborates with trusted logistics partners to ensure expedited delivery, with kits reaching clients in under half a day in the Beijing area and within five days across the country. Additionally, the company provides tailored microbiome testing services to institutional clients, utilizing a variety of customized tools, including samplers, experimental kits, quantitative testing equipment, and analysis systems. Through these services, QuantiHealth aims to enhance the accuracy and reliability of microbial testing in various applications.

Cygnus Biosciences (Beijing) Co., Ltd. is a biotechnology firm focused on the research and development of gene sequencing platforms. The company is dedicated to the industrialization of these technologies for clinical medicine screening and diagnosis. By leveraging advanced gene sequencing technology, Cygnus provides accurate and efficient biotech solutions, enabling genetic engineers and gene therapy specialists to obtain reliable data inputs and readings. This capability supports researchers in conducting experiments and deriving conclusions with enhanced effectiveness and minimal error. Through its innovative approach, Cygnus Biosciences aims to advance the field of genetics and improve clinical outcomes.